Lipocine
LPCN
#9683
Rank
NZ$45.41 M
Marketcap
$8.49
Share price
-1.44%
Change (1 day)
81.84%
Change (1 year)

Operating Margin for Lipocine (LPCN)

Operating Margin as of December 2024 (TTM): -195.69%

According to Lipocine's latest financial reports and stock price the company's current Operating Margin is -195.69%. At the end of 2023 the company had an Operating Margin of -573.57%.

Operating Margin history for Lipocine from 2021 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2023-573.57%-73.34%
2022-2,151.59%54659.6%
2021-3.93%
2019-7,883.60%189.42%
2018-2,723.94%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
-30.69%-84.32%๐Ÿ‡บ๐Ÿ‡ธ USA
9.98%-105.10%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
-69.66%-64.40%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.